Mesenchymal Stem Cells in Regenerative Medicine for Musculoskeletal Diseases: Bench, Bedside, and Industry

被引：62
|
作者：
Wei, Chih-Chang [1 ]
Lin, Andrew Boyd [2 ]
Hung, Shih-Chieh [1 ,3 ,4 ,5 ,6 ,7 ]
机构：
[1] Taipei Vet Gen Hosp, Stem Cell Lab, Dept Med Res & Educ, Taipei, Taiwan
[2] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA
[3] Taipei Vet Gen Hosp, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
[5] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
[6] Natl Yang Ming Univ, Inst Pharmacol, Fac Med, Taipei 112, Taiwan
[7] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan
来源：
CELL TRANSPLANTATION | 2014年 / 23卷 / 4-5期
关键词：
Mesenchymal stem cells (MSCs); Musculoskeletal diseases (MSDs); Preclinical animal studies; Clinical trials; Industry; MARROW STROMAL CELLS; THERAPY POSITION STATEMENT; BONE-MARROW; IN-VITRO; CONDITIONED MEDIUM; CARTILAGE DEFECTS; OSTEOGENESIS IMPERFECTA; INTERNATIONAL-SOCIETY; ARTICULAR-CARTILAGE; MUSCLE-FIBER;
D O I：
10.3727/096368914X678328
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Human bone marrow-derived mesenchymal stem cells (MSCs) can self-renew and differentiate into osteoblasts, chondrocytes, and adipocytes. MSCs have effectively emerged as a promising tool for clinical applications, specifically in musculoskeletal diseases. This article reviews the status of preclinical animal studies, clinical trials, and the efforts of the industry in using MSCs to treat musculoskeletal diseases such as bone fractures, bone defects, focal chondral lesions, osteoarthritis, spinal diseases, and tendon injuries. We also discuss the current problems encountered and potential of using MSCs in future clinical studies.
引用
收藏
页码：505 / 512
页数：8
相关论文
共 50 条
  • [1] Stem cells in regenerative medicine - from bench to bedside
    Klietz, Marie-Luise
    Kueckelhaus, Maximilian
    Kaiser, Hans Wilhelm
    Raschke, Michael J.
    Hirsch, Tobias
    Aitzetmueller, Matthias
    HANDCHIRURGIE MIKROCHIRURGIE PLASTISCHE CHIRURGIE, 2020, 52 (04) : 338 - 349
  • [2] Mesenchymal stem cells and connective tissue diseases: From bench to bedside
    Shi, Yue
    Jiang, Nan
    Li, Mengtao
    Zeng, Xiaofeng
    Tian, Xinping
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2022, 11 (01) : 30 - 45
  • [3] Hydrogels empowered mesenchymal stem cells and the derived exosomes for regenerative medicine in age-related musculoskeletal diseases
    Liu, Lixin
    Chen, Siwen
    Song, Yantao
    Cui, Longwei
    Chen, Yiman
    Xia, Jiangli
    Fan, Yibo
    Yang, Liqun
    Yang, Lina
    PHARMACOLOGICAL RESEARCH, 2025, 213
  • [4] Mesenchymal Stem Cells and Regenerative Medicine
    Sumer, Huseyin
    Liu, Jun
    Roh, Sangho
    STEM CELLS INTERNATIONAL, 2018, 2018
  • [5] Mesenchymal Stem Cells for Regenerative Medicine
    Han, Yu
    Li, Xuezhou
    Zhang, Yanbo
    Han, Yuping
    Chang, Fei
    Ding, Jianxun
    CELLS, 2019, 8 (08)
  • [6] Bench to bedside: Current advances in regenerative medicine
    Clarke, Gabriella
    Harley, Peter
    Hubber, Ella-Louise
    Manea, Teodora
    Manuelli, Luigi
    Read, Emily
    Watt, Fiona M.
    CURRENT OPINION IN CELL BIOLOGY, 2018, 55 : 59 - 66
  • [7] Regenerative medicine: ethics from bench to bedside
    Bredenoord, A. L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 : 2 - 2
  • [8] Transplantation of Mesenchymal Stem Cells as a New Approach for Cardiovascular Diseases: From Bench to Bedside: A Perspective
    Caiati, Carlo
    Jirillo, Emilio
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (11) : 1359 - 1364
  • [9] Mesenchymal Stem Cells and Cardiovascular Disease: A Bench to Bedside Roadmap
    Mazo, Manuel
    Arana, Miriam
    Pelacho, Beatriz
    Prosper, Felipe
    STEM CELLS INTERNATIONAL, 2012, 2012
  • [10] Mesenchymal stem cells in regenerative medicine: a new paradigm for degenerative bone diseases
    Shyam, Hari
    Singh, Satyendra K.
    Kant, Ravi
    Saxena, Shailendra K.
    REGENERATIVE MEDICINE, 2017, 12 (02) : 111 - 114
12345